Ken Fisher's PFE Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 49.29 M shares of Pfizer Inc. (PFE) worth $1.26 B, representing 0.45% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Ken Fisher has maintained a long-term strategic position in PFE, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2025, adding 36.29 M shares. Largest reduction occurred in Q1 2020, reducing 39.93 M shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Pfizer (PFE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pfizer (PFE) Trades by Ken Fisher
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +30.74 M | Add 0.00% | 30.74 M | $28.01 |
| Q3 2013 | -25,787 | Reduce 0.08% | 30.71 M | $28.73 |
| Q4 2013 | -271,348 | Reduce 0.88% | 30.44 M | $30.63 |
| Q1 2014 | -200,285 | Reduce 0.66% | 30.24 M | $32.12 |
| Q2 2014 | +1.24 M | Add 4.10% | 31.48 M | $29.68 |
| Q3 2014 | +220,006 | Add 0.70% | 31.7 M | $29.57 |
| Q4 2014 | -506,080 | Reduce 1.60% | 31.2 M | $31.15 |
| Q1 2015 | +11,856 | Add 0.04% | 31.21 M | $34.79 |
| Q2 2015 | +608,478 | Add 1.95% | 31.82 M | $33.53 |
| Q3 2015 | +110,130 | Add 0.35% | 31.93 M | $31.41 |
| Q4 2015 | +407,538 | Add 1.28% | 32.33 M | $32.28 |
| Q1 2016 | -588,269 | Reduce 1.82% | 31.75 M | $32.50 |
| Q2 2016 | -21,618 | Reduce 0.07% | 31.72 M | $36.15 |
| Q3 2016 | +111,838 | Add 0.35% | 31.84 M | $33.87 |
| Q4 2016 | +368,385 | Add 1.16% | 32.2 M | $32.48 |
| Q1 2017 | +554,777 | Add 1.72% | 32.76 M | $34.21 |
| Q2 2017 | +1.28 M | Add 3.89% | 34.04 M | $33.59 |
| Q3 2017 | +1.09 M | Add 3.19% | 35.12 M | $35.70 |
| Q4 2017 | +1.25 M | Add 3.56% | 36.37 M | $36.22 |
| Q1 2018 | +1.4 M | Add 3.85% | 37.77 M | $35.49 |
| Q2 2018 | +1.67 M | Add 4.42% | 39.45 M | $36.28 |
| Q3 2018 | +1.03 M | Add 2.62% | 40.48 M | $44.07 |
| Q4 2018 | +1.35 M | Add 3.34% | 41.83 M | $43.65 |
| Q1 2019 | +743,137 | Add 1.78% | 42.57 M | $42.47 |
| Q2 2019 | +1.56 M | Add 3.66% | 44.13 M | $43.32 |
| Q3 2019 | +1.16 M | Add 2.62% | 45.29 M | $35.93 |
| Q4 2019 | +83,775 | Add 0.18% | 45.38 M | $39.18 |
| Q1 2020 | -39.93 M | Reduce 87.99% | 5.45 M | $32.64 |
| Q2 2020 | -3 M | Reduce 54.99% | 2.45 M | $32.70 |
| Q3 2020 | -82,334 | Reduce 3.36% | 2.37 M | $36.70 |
| Q4 2020 | +173,845 | Add 7.34% | 2.54 M | $36.81 |
| Q1 2021 | -58,521 | Reduce 2.30% | 2.49 M | $36.23 |
| Q2 2021 | -38,794 | Reduce 1.56% | 2.45 M | $39.16 |
| Q3 2021 | -2,276 | Reduce 0.09% | 2.44 M | $43.01 |
| Q4 2021 | +63,262 | Add 2.59% | 2.51 M | $59.05 |
| Q1 2022 | -34,667 | Reduce 1.38% | 2.47 M | $51.77 |
| Q2 2022 | -12,419 | Reduce 0.50% | 2.46 M | $52.43 |
| Q3 2022 | -404,984 | Reduce 16.46% | 2.06 M | $43.76 |
| Q4 2022 | -99,745 | Reduce 4.85% | 1.96 M | $51.24 |
| Q1 2023 | -31,983 | Reduce 1.64% | 1.92 M | $40.80 |
| Q2 2023 | +463 | Add 0.02% | 1.92 M | $36.68 |
| Q3 2023 | +9,537 | Add 0.50% | 1.93 M | $33.17 |
| Q4 2023 | -46,423 | Reduce 2.40% | 1.89 M | $28.79 |
| Q1 2024 | +15,888 | Add 0.84% | 1.9 M | $27.75 |
| Q2 2024 | -2,394 | Reduce 0.13% | 1.9 M | $27.98 |
| Q3 2024 | +4.31 M | Add 226.69% | 6.21 M | $28.94 |
| Q4 2024 | +4.94 M | Add 79.52% | 11.15 M | $26.53 |
| Q1 2025 | +36.29 M | Add 325.54% | 47.44 M | $25.34 |
| Q2 2025 | +950,239 | Add 2.00% | 48.39 M | $24.24 |
| Q3 2025 | +897,786 | Add 1.86% | 49.29 M | $25.48 |
Ken Fisher's Pfizer Investment FAQs
Ken Fisher first purchased Pfizer Inc. (PFE) in Q2 2013, acquiring 30,739,957 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Pfizer Inc. (PFE) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's largest addition to Pfizer Inc. (PFE) was in Q1 2025, adding 47,440,029 shares worth $1.2 B. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 49,288,054 shares of Pfizer Inc. (PFE), valued at approximately $1.26 B. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Pfizer Inc. (PFE) represents approximately 0.45% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's peak holding in Pfizer Inc. (PFE) was 49,288,054 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.